Feasibility of Patient Reporting of Symptomatic Adverse Events via the PRO-CTCAE in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial

PURPOSE: To assess the feasibility of measuring symptomatic adverse events (AEs) in a multicenter clinical trial using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). METHODS AND MATERIALS: Patients enrolled in Tria...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Basch, Ethan, Pugh, Stephanie L, Dueck, Amylou C, Mitchell, Sandra A, Berk, Lawrence, Fogh, Shannon, Rogak, Lauren J, Gatewood, Marcha, Reeve, Bryce B, Mendoza, Tito R, O’Mara, Ann, Denicoff, Andrea, Minasian, Lori, Bennett, Antonia V, Setser, Ann, Schrag, Deborah, Roof, Kevin, Moore, Joan K, Gergel, Thomas, Stephans, Kevin, Rimner, Andreas, DeNittis, Albert, Bruner, Deborah Watkins
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557037/
https://ncbi.nlm.nih.gov/pubmed/28463161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2017.02.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados